Immucell (ICCC) Other Operating Expenses (2010 - 2025)
Immucell's (ICCC) quarterly Other Operating Expenses came in at $486643.0 in Q4 2025, up 3243.02% YoY from $14557.0 in Q4 2024, and up 880.89% on a QoQ basis from -$62319.0 in Q3 2025.
Immucell (ICCC) Other Operating Expenses (2010 - 2025) Analysis & Trends
Immucell (ICCC) has 16 years of Other Operating Expenses data on file, last reported at $486643.0 in Q4 2025.
- Quarterly Other Operating Expenses rose 3243.02% year-over-year to $486643.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $426587.0 (down 66.21% YoY) and the FY2025 annual result came in at $426587.0, changed N/A from the prior year.
- Other Operating Expenses climbed to $486643.0 in Q4 2025, from -$62319.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $1.3 million in Q3 2022 to a low of -$619008.0 in Q2 2022.
- A 5-year average of $396994.3 and a median of $250600.0 in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 15416.63% in 2024, down 19005.19% in 2024.
- Tracing ICCC's Other Operating Expenses over 5 years: stood at $889929.0 in 2021, then tumbled by 128.59% to -$254431.0 in 2022, then surged by 421.3% to $817486.0 in 2023, then sank by 98.22% to $14557.0 in 2024, then soared by 3243.02% to $486643.0 in 2025.
- The last three Other Operating Expenses figures came in at $486643.0 (Q4 2025), -$62319.0 (Q3 2025), and $7128.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 486,643.00 |
| Sep 30, 2025 | -62,319.00 |
| Jun 30, 2025 | 7,128.00 |
| Mar 31, 2025 | -4,865.00 |
| Dec 31, 2024 | 14,557.00 |
| Jun 30, 2024 | -14,557.00 |
| Mar 31, 2024 | 1.26 Mn |
| Sep 30, 2023 | 817,486.00 |
| Jun 30, 2023 | 77.00 |
| Mar 31, 2023 | -8,243.00 |
| Dec 31, 2022 | -254,431.00 |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | -619,008.00 |
| Mar 31, 2022 | 792,988.00 |
| Dec 31, 2021 | 889,929.00 |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 520,597.00 |
| Dec 31, 2020 | 1.17 Mn |
| Sep 30, 2020 | 459,117.00 |